Figure 6From: A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study Coagulation markers (Safety population*). Legend: *109 patients were available for evaluation at baseline (V2) and 103 patients at week 8 (V4).Back to article page